Daewoong Unveiled Breakthrough Diabetes Treatment at ADA Conference
Rabu, 26 Juni 2024 - 23:00 WIB
Sumber :
- Pexels/Mikhail Nilov
These results are supported by Phase 3 clinical trials involving patients with type 2 diabetes, confirming the favorable safety profile of Enavogliflozin.